ASO Author Reflections: Can We Target a Postoperative Hypercoagulable State in the Acute Phase after Esophagectomy for Esophageal Cancer?

Junichi Sano; Satoru Matsuda; Hirofumi Kawakubo; Ryo Takemura; Jun Okui; Tomoyuki Irino; Kazumasa Fukuda; Rieko Nakamura; Yuko Kitagawa

doi:10.1245/s10434-022-11660-8

ASO Author Reflections: Can We Target a Postoperative Hypercoagulable State in the Acute Phase after Esophagectomy for Esophageal Cancer?

Junichi Sano, Satoru Matsuda, Hirofumi Kawakubo, Ryo Takemura, Jun Okui, Tomoyuki Irino, Kazumasa Fukuda, Rieko Nakamura, Yuko Kitagawa

研究成果: Comment/debate › 査読

本文言語	English
ページ（範囲）	4498-4499
ページ数	2
ジャーナル	Annals of Surgical Oncology
巻	29
号	7
DOI	https://doi.org/10.1245/s10434-022-11660-8
出版ステータス	Published - 2022 7月

ASJC Scopus subject areas

外科
腫瘍学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1245/s10434-022-11660-8

他のファイルとリンク

引用スタイル

@article{0cac7328e355429b8535b9b4dd73c653,

title = "ASO Author Reflections: Can We Target a Postoperative Hypercoagulable State in the Acute Phase after Esophagectomy for Esophageal Cancer?",

author = "Junichi Sano and Satoru Matsuda and Hirofumi Kawakubo and Ryo Takemura and Jun Okui and Tomoyuki Irino and Kazumasa Fukuda and Rieko Nakamura and Yuko Kitagawa",

note = "Funding Information: Kazumasa Fukuda—I belong to the Keio University School of Medicine Endowed Chair in Cancer Research funded by CHUGAI PHARMACEUTICAL CO., LTD and TAIHO PHARMACEUTICAL CO., LTD. Yuko Kitagawa, relevant financial activities outside the submitted work: Takeda Pharmaceutical Co., Ltd., CHUGAI PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD, Yakult Honsha Co. Ltd., ASAHI KASEI PHARMA CORPORATION, Otsuka Pharmaceutical Co., Ltd., ONO PHARMACEUTICAL CO., LTD. ",

year = "2022",

month = jul,

doi = "10.1245/s10434-022-11660-8",

language = "English",

volume = "29",

pages = "4498--4499",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "7",

}

TY - JOUR

T1 - ASO Author Reflections

T2 - Can We Target a Postoperative Hypercoagulable State in the Acute Phase after Esophagectomy for Esophageal Cancer?

AU - Sano, Junichi

AU - Matsuda, Satoru

AU - Kawakubo, Hirofumi

AU - Takemura, Ryo

AU - Okui, Jun

AU - Irino, Tomoyuki

AU - Fukuda, Kazumasa

AU - Nakamura, Rieko

AU - Kitagawa, Yuko

N1 - Funding Information: Kazumasa Fukuda—I belong to the Keio University School of Medicine Endowed Chair in Cancer Research funded by CHUGAI PHARMACEUTICAL CO., LTD and TAIHO PHARMACEUTICAL CO., LTD. Yuko Kitagawa, relevant financial activities outside the submitted work: Takeda Pharmaceutical Co., Ltd., CHUGAI PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD, Yakult Honsha Co. Ltd., ASAHI KASEI PHARMA CORPORATION, Otsuka Pharmaceutical Co., Ltd., ONO PHARMACEUTICAL CO., LTD.

PY - 2022/7

Y1 - 2022/7

UR - http://www.scopus.com/inward/record.url?scp=85127386962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127386962&partnerID=8YFLogxK

U2 - 10.1245/s10434-022-11660-8

DO - 10.1245/s10434-022-11660-8

M3 - Comment/debate

C2 - 35359170

AN - SCOPUS:85127386962

SN - 1068-9265

VL - 29

SP - 4498

EP - 4499

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 7

ER -